organization · Reporting owner
WP X Finance, L.P.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Outset Medical, Inc.
Report date April 13, 2021 · Filed April 15, 2021
Jointly reported with Warburg Pincus X, L.P., Warburg Pincus X Partners, L.P., WPX GP, L.P., Warburg Pincus Private Equity X, L.P., Warburg Pincus X GP L.P., WPP GP LLC, Warburg Pincus Partners, L.P., Warburg Pincus Partners GP LLC, WARBURG PINCUS & CO.
Section 16 reporting ended · disclosed 2021-04-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 26,086 |
Reported balance
After 2021-04-13 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-04-13 · Sale · Disposed 120,612 · Balance 26,086 F1: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. |
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 815,394 |
Reported balance
After 2021-04-13 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-04-13 · Sale · Disposed 3,770,111 · Balance 815,394 F2: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners").
F2: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP.
F3: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds.
Silk Road Medical Inc
Report date May 05, 2020 · Filed May 07, 2020
Jointly reported with WPX GP, L.P., Warburg Pincus Private Equity X, L.P., Warburg Pincus X Partners, L.P., Warburg Pincus X, L.P., Warburg Pincus X GP L.P., WPP GP LLC, Warburg Pincus Partners, L.P., Warburg Pincus Partners GP LLC
Section 16 reporting ended · disclosed 2020-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,021,223 |
Reported balance
After 2020-05-05 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-05-05 · Sale · Disposed 4,885,078 · Balance 1,021,223 F1: In connection with the Issuer's public offering, 4,733,641 shares were sold by WP X Finance, L.P. ("WP X Finance"), and 151,437 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP"), each to the underwriters of the public offering. F2: Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), on May 5, 2020, the Issuer, WP X Finance, WPXP and the underwriters of the Offering (the "Underwriter"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,885,078 shares of common stock of the issuer to the Underwriters. The per share sale price reported in this Form 4 does not reflect underwriting discounts. F3: 989,570 of these shares are held by WP X Finance and 31,653 of these shares are held by WPXP. F4: WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. F5: (continuation from footnote 4) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is the manager of WP X Finance, WPXP, and WP X. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the Issuer's public offering, 4,733,641 shares were sold by WP X Finance, L.P. ("WP X Finance"), and 151,437 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP"), each to the underwriters of the public offering.
F2: Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), on May 5, 2020, the Issuer, WP X Finance, WPXP and the underwriters of the Offering (the "Underwriter"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,885,078 shares of common stock of the issuer to the Underwriters. The per share sale price reported in this Form 4 does not reflect underwriting discounts.
F3: 989,570 of these shares are held by WP X Finance and 31,653 of these shares are held by WPXP.
F4: WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners.
F5: (continuation from footnote 4) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is the manager of WP X Finance, WPXP, and WP X.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2021 Filed Apr 15, 2021 22:47 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,770,111 | $50.83 | $191,615,891.58 |
DisclosureSEC source: 0001140361-21-012984 · form4.xml · nonDerivative · entry 2 Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 815,394 F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:47 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 120,612 | $50.83 | $6,130,104.90 |
DisclosureSEC source: 0001140361-21-012984 · form4.xml · nonDerivative · entry 1 Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 26,086 F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 535,793 | $50.35 | $26,977,177.55 |
DisclosureSEC source: 0001140361-21-000496 · form4.xml · nonDerivative · entry 2 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,585,505 F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 17,141 | $50.35 | $863,049.35 |
DisclosureSEC source: 0001140361-21-000496 · form4.xml · nonDerivative · entry 1 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 146,698 F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,571,953 | $50.35 | $179,847,833.55 |
DisclosureSEC source: 0000905148-20-001260 · form4.xml · nonDerivative · entry 2 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,121,298 F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 114,272 | $50.35 | $5,753,595.20 |
DisclosureSEC source: 0000905148-20-001260 · form4.xml · nonDerivative · entry 1 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 163,839 F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries D Redeemable Convertible Preferred Stock · Derivative | 3,115,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 10 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 520,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F9 · derivative.exercise_date: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F9 · derivative.expiration_date: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries D Redeemable Convertible Preferred Stock · Derivative | 99,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 9 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 16,655 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F9 · derivative.exercise_date: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F9 · derivative.expiration_date: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries C Redeemable Convertible Preferred Stock · Derivative | 5,608,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 8 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 709,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F8 · derivative.exercise_date: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F8 · derivative.expiration_date: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries C Redeemable Convertible Preferred Stock · Derivative | 179,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 7 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 22,713 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F8 · derivative.exercise_date: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F8 · derivative.expiration_date: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries B Redeemable Convertible Preferred Stock · Derivative | 11,410,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 6 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 1,299,946 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F7 · derivative.exercise_date: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F7 · derivative.expiration_date: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries B Redeemable Convertible Preferred Stock · Derivative | 365,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 5 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 41,587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F7 · derivative.exercise_date: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F7 · derivative.expiration_date: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries A Redeemable Convertible Preferred Stock · Derivative | 38,614,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 4 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 3,666,039 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F6 · derivative.exercise_date: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F6 · derivative.expiration_date: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionSeries A Redeemable Convertible Preferred Stock · Derivative | 1,235,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · derivative · entry 3 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 117,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F6 · derivative.exercise_date: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F6 · derivative.expiration_date: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionCommon Stock | 6,196,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · nonDerivative · entry 2 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,693,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F7 · price: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F8 · price: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F9 · price: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F2 · ownership.direct: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F2 · ownership.nature: These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:29 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionCommon Stock | 198,238 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-20-020800 · form4.xml · nonDerivative · entry 1 Warburg Pincus X, L.P. · CIK 0001414561 · Director · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · Director · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · Director · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · Director · 10% owner WPX GP, L.P. · CIK 0001770772 · Director · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · Director · 10% owner WP X Finance, L.P. · CIK 0001770767 · Director · 10% owner WPP GP LLC · CIK 0001621874 · Director · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · Director · 10% owner WARBURG PINCUS & CO. · CIK 0000929408 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 278,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date. F7 · price: The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date. F8 · price: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F9 · price: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F1 · ownership.direct: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.direct: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.direct: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.direct: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. F1 · ownership.nature: These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners"). F3 · ownership.nature: Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds. F4 · ownership.nature: Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities." F5 · ownership.nature: Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:50 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 4,885,078 | $39.00 | $190,518,042.00 |
DisclosureSEC source: 0000899243-20-012345 · doc4.xml · nonDerivative · entry 1 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,021,223 F1 · shares: In connection with the Issuer's public offering, 4,733,641 shares were sold by WP X Finance, L.P. ("WP X Finance"), and 151,437 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP"), each to the underwriters of the public offering. F2 · price: Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), on May 5, 2020, the Issuer, WP X Finance, WPXP and the underwriters of the Offering (the "Underwriter"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,885,078 shares of common stock of the issuer to the Underwriters. The per share sale price reported in this Form 4 does not reflect underwriting discounts. F3 · balance_after: 989,570 of these shares are held by WP X Finance and 31,653 of these shares are held by WPXP. F4 · balance_after: WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. F5 · balance_after: (continuation from footnote 4) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is the manager of WP X Finance, WPXP, and WP X. Read SEC document |
| November 26, 2019 Filed Nov 29, 2019 16:05 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 1,500,000 | $35.00 | $52,500,000.00 |
DisclosureSEC source: 0001628280-19-014604 · wf-form4_157506149674092.xml · nonDerivative · entry 1 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,906,301 F1 · shares: 1,453,500 shares were sold by WP X Finance, L.P. ("WP X Finance") and 46,500 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP"). F2 · balance_after: 5,723,211 of these shares are held by WP X Finance and 183,090 of these shares are held by WPXP. F3 · balance_after: WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. F4 · balance_after: (continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is the manager of WP X Finance, WPXP, and WP X. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and Co-Chief Executive Officers and Managing Members of WP LLC, and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:03 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 630,000 | $39.50 | $24,885,000.00 |
DisclosureSEC source: 0001628280-19-010823 · wf-form4_156589941944134.xml · nonDerivative · entry 1 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,406,301 F1 · shares: Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), 610,470 shares were sold by WP X Finance, L.P. ("WP X Finance") and 19,530 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP") upon exercise of the underwriter's overallotment option. F2 · price: Pursuant to the Offering, on August 8, 2019, the Issuer, WP X Finance, WPXP, other selling stockholders, and the underwriters of the Offering (the "Underwriters"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,793,328 shares of common stock of the Issuer to the Underwriters, including an aggregate of 630,000 shares upon exercise of the Underwriters' overallotment option. The per share sale price reported in this Form 4 does not reflect underwriting discounts. F3 · balance_after: 7,176,711 of these shares are held by WP X Finance and 229,590 of these shares are held by WPXP. F4 · balance_after: WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. F5 · balance_after: (continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 18:37 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 4,163,328 | $39.50 | $164,451,456.00 |
DisclosureSEC source: 0001628280-19-010643 · wf-form4_156564944789688.xml · nonDerivative · entry 1 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,036,301 F1 · shares: In connection with the Issuer's follow-on public offering, 4,034,265 shares were sold by WP X Finance, L.P. ("WP X Finance"), and 129,063 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP"), each to the underwriters of the follow-on public offering. F2 · price: Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), on August 8, 2019, the Issuer, WP X Finance, WPXP, other selling stockholders, and the underwriters of the Offering (the "Underwriter"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,163,328 shares of common stock of the issuer to the Underwriters. The per share sale price reported in this Form 4 does not reflect underwriting discounts. F3 · balance_after: 7,787,181 of these shares are held by "WP X Finance" and 249,120 of these shares are held by Warburg Pincus X Partners, L.P. ("WPXP"). F4 · balance_after: WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WPX and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. F5 · balance_after: (continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | ConversionSeries C Preferred Stock · Derivative | 1,538,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 13 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,538,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F9 · kind: WP X Finance exercised a warrant to purchase 1,071,902 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 327,467 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 744,435 shares. F12 · kind: WP X Finance exercised a warrant to purchase 1,074,072 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 328,129 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 745,943 shares. F13 · kind: WPXP exercised a warrant to purchase 34,291 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,476 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,815 shares. F15 · kind: WPXP exercised a warrant to purchase 34,361 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,498 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,863 shares. F20 · shares: Prior to conversion to Common Stock, these shares are comprised of 1,490,378 shares held by WPX Finance and 47,678 shares held by WPXP. F1 · derivative.exercise_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F20 · ownership.direct: Prior to conversion to Common Stock, these shares are comprised of 1,490,378 shares held by WPX Finance and 47,678 shares held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock · Derivative | 20,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 12 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,678 Underlying: Common Stock · 20,974 shares Expires not disclosed F1 · derivative.exercise_price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F13 · kind: WPXP exercised a warrant to purchase 34,291 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,476 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,815 shares. F15 · kind: WPXP exercised a warrant to purchase 34,361 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,498 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,863 shares. F19 · shares: These shares are comprised of 10,476 shares and 10,498 shares withheld by the Issuer pursuant to the net exercise of warrants, as detailed in footnotes (13) and (15). F1 · derivative.exercise_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F17 · ownership.direct: These shares are held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock · Derivative | 655,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 11 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490,378 Underlying: Common Stock · 655,596 shares Expires not disclosed F1 · derivative.exercise_price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F9 · kind: WP X Finance exercised a warrant to purchase 1,071,902 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 327,467 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 744,435 shares. F12 · kind: WP X Finance exercised a warrant to purchase 1,074,072 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 328,129 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 745,943 shares. F18 · shares: These shares are comprised of 327,467 shares and 328,129 shares withheld by the Issuer pursuant to the net exercise of warrants, as detailed in footnotes (9) and (12). F1 · derivative.exercise_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F16 · ownership.direct: These shares are held by WP X Finance. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock · Derivative | 68,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 10 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,652 Underlying: Common Stock · 68,652 shares Expires not disclosed F1 · derivative.exercise_price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F13 · kind: WPXP exercised a warrant to purchase 34,291 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,476 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,815 shares. F15 · kind: WPXP exercised a warrant to purchase 34,361 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,498 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,863 shares. F1 · derivative.exercise_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F17 · ownership.direct: These shares are held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock · Derivative | 2,145,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 9 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,145,974 Underlying: Common Stock · 2,145,974 shares Expires not disclosed F1 · derivative.exercise_price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F9 · kind: WP X Finance exercised a warrant to purchase 1,071,902 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 327,467 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 744,435 shares. F12 · kind: WP X Finance exercised a warrant to purchase 1,074,072 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 328,129 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 745,943 shares. F1 · derivative.exercise_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F16 · ownership.direct: These shares are held by WP X Finance. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock Warrant (Right to buy) · Derivative | 34,361 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 8 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,361 shares Expires 2023-10-13 F15 · kind: WPXP exercised a warrant to purchase 34,361 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,498 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,863 shares. F10 · derivative.exercise_date: All of the shares subject to the warrant are fully exercisable as of the date hereof. F14 · ownership.direct: This warrant is held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock Warrant (Right to buy) · Derivative | 34,291 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 7 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,291 shares Expires 2022-08-07 F13 · kind: WPXP exercised a warrant to purchase 34,291 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WPXP paid the exercise price on a cashless basis, resulting in the Issuer withholding 10,476 of the warrant shares to pay the exercise price and issued to WPXP the remaining 23,815 shares. F10 · derivative.exercise_date: All of the shares subject to the warrant are fully exercisable as of the date hereof. F14 · ownership.direct: This warrant is held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock Warrant (Right to buy) · Derivative | 1,074,072 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 6 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,074,072 shares Expires 2023-10-13 F12 · kind: WP X Finance exercised a warrant to purchase 1,074,072 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 328,129 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 745,943 shares. F10 · derivative.exercise_date: All of the shares subject to the warrant are fully exercisable as of the date hereof. F11 · ownership.direct: This warrant is held by WP X Finance. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | OtherSeries C Preferred Stock Warrant (Right to buy) · Derivative | 1,071,902 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 5 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,071,902 shares Expires 2022-08-07 F9 · kind: WP X Finance exercised a warrant to purchase 1,071,902 shares of the Issuer's Series C Preferred Stock at a per share exercise price of $6.11. WP X Finance paid the exercise price on a cashless basis, resulting in the Issuer withholding 327,467 of the warrant shares to pay the exercise price and issued to WP X Finance the remaining 744,435 shares. F10 · derivative.exercise_date: All of the shares subject to the warrant are fully exercisable as of the date hereof. F11 · ownership.direct: This warrant is held by WP X Finance. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | ConversionSeries C Preferred Stock · Derivative | 5,904,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 4 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,904,180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.exercise_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F8 · ownership.direct: 5,721,152 of these shares are held by WP X Finance and 183,028 of these shares are held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | ConversionSeries B Preferred Stock · Derivative | 5,637,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · derivative · entry 3 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,637,492 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.exercise_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F7 · ownership.direct: 5,462,731 of these shares are held by WP X Finance and 174,761 of these shares are held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 900,000 | $20.00 | $18,000,000.00 |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · nonDerivative · entry 2 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,199,629 F5 · kind: 872,100 shares were sold by WP X Finance, and 27,900 shares were sold by WPXP, each in connection with the exercise of the underwriter's overallotment option pursuant to the Issuer's initial public offering of Common Stock. F6 · balance_after: 11,821,446 of these shares are held by WP X Finance and 378,183 of these shares are held by WPXP. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 21:58 UTC | Silk Road Medical Inc SILK · Entity 87417 | ConversionCommon Stock | 13,079,728 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-004178 · wf-form4_155494791134305.xml · nonDerivative · entry 1 WP X Finance, L.P. · CIK 0001770767 · 10% owner WPX GP, L.P. · CIK 0001770772 · 10% owner Warburg Pincus Private Equity X, L.P. · CIK 0001414565 · 10% owner Warburg Pincus X Partners, L.P. · CIK 0001451560 · 10% owner Warburg Pincus X, L.P. · CIK 0001414561 · 10% owner Warburg Pincus X GP L.P. · CIK 0001414564 · 10% owner WPP GP LLC · CIK 0001621874 · 10% owner Warburg Pincus Partners, L.P. · CIK 0001621242 · 10% owner Warburg Pincus Partners GP LLC · CIK 0001621224 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,099,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series B Preferred Stock and Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · balance_after: 12,693,546 of these shares are held by WP X Finance, L.P. ("WP X Finance") and 406,083 of these shares are held by Warburg Pincus X Partners, L.P. ("WPXP"). The total of 13,099,629 shares beneficially owned is comprised of (i) 19,901 shares of Common Stock held prior to the date hereof (ii) 5,637,492 shares of Common Stock issued upon conversion of Series B Preferred Stock held prior to the date hereof, (iii) 5,904,180 shares of Common Stock issued upon conversion of Series C Preferred Stock held prior to the date hereof, and (iv) 1,538,056 shares of Common Stock issued upon conversion of Series C Preferred Stock issued pursuant to the net exercise of warrants, as detailed in footnotes (9), (12), (13) and (15). F3 · balance_after: WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WPX and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. F4 · balance_after: (continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.